[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-02-P] Development of a split and universal Chimeric Antigen Receptor system targeting solid tumors

^○Hiroyuki Kadota, Tsukasa Shigehiro, Yuki Narita, Shogo Tanimori, Jia Han, Tomokatsu Ikawa (Tokyo University of Science, Research Institute for Biomedical Sciences)

キーワード：

CAR-T/CAR-NK、split CAR、immune cell therapy、solid tumor

閲覧にはパスワードが必要です

ログイン

または